Respiratory Therapeutic Devices Market Outlook: Regional Perspectives and Market Entry Strategies
Ngày đăng: 07-02-2024 |
Ngày cập nhật: 07-02-2024
Market Highlights
The Respiratory Therapeutic Devices Market comprises a range of medical devices aimed at managing respiratory conditions like COPD, asthma, and sleep apnea. These devices, including inhalers, PAP machines, oxygen therapy, and ventilators, address diverse respiratory needs. Market growth is propelled by rising respiratory disease prevalence, technological advancements enhancing device efficacy and portability, and a focus on personalized care. Key players in this competitive market prioritize innovation and strategic partnerships to meet evolving patient demands. As the global burden of respiratory diseases continues to grow, the market is poised for further expansion in meeting patient needs and improving respiratory health outcomes.
The Respiratory Therapeutic Devices Market Size is anticipated to reach USD 12,231.6 Million by 2030 at 8.6% CAGR during the forecast period 2022-2030.
Breathing assistance devices are another key segment of the respiratory therapeutic devices market, aimed at providing assistance to individuals with compromised respiratory function. These devices include continuous positive airway pressure (CPAP) machines, bilevel positive airway pressure (BiPAP) machines, and nebulizers, among others. CPAP and BiPAP machines are commonly used to treat sleep apnea and other sleep-related breathing disorders by delivering a steady flow of air to keep the airways open during sleep. Nebulizers are used to deliver medication in the form of a mist or aerosol to the lungs, providing relief for respiratory conditions such as asthma and chronic bronchitis. The growing awareness of the importance of early diagnosis and treatment of respiratory conditions, coupled with technological advancements in breathing assistance devices, is driving market growth.
Key Players
Global Respiratory Therapeutic Devices Market Players are
Masimo. (U.S.),
Rotech Healthcare Inc. (U.S.),
Chart Industries (U.S.),
Acare Technology (Asia Pacific), and
others.
Segmentation
The global respiratory therapeutic devices market is segmented on the basis of product, technology, application, and end users.
On the basis of the product, the market is segmented into nebulizers, capnography, humidifiers oxygen concentrators, and others. The nebulizers segment is sub-segmented into soft mist inhaler, human-powered nebulizer, and others. The capnography segment is sub-segmented into main-stream capnography, side-stream capnography, and others.
On the basis of the technology, the market is segmented into electrostatic filtration, HEPA filtration, hollow fiber filtration, microsphere separation, and others.
On the basis of the application, the market is segmented into asthma, chronic obstructive pulmonary disease (COPD), cystic fibrosis, and others.
On the basis of the end users, the market is segmented into hospitals & clinics, retail pharmacies, home care, and others.
Regional Analysis
The Americas dominate the global respiratory therapeutic devices market insights owing to a huge patient population having cardiopulmonary diseases and well-developed healthcare sector. Moreover, the concentration of the global players like Masimo., BD., Smiths Group plc., besides others along with the increasing healthcare expenditure fuels the regional market growth during the forecast period. In 2015, according to the Centers for Disease Control and Prevention, in the U.S. the total healthcare expenditure accounted for 17.8% of the total gross domestic product (GDP), which accounted for USD 3.2 trillion.
Europe is the second largest respiratory therapeutic devices market owing to a well-developed healthcare infrastructure, government support for research & development, and huge patient population. In 2017, according to a study published in the Asthma Research and Practice Journal, the total estimated cost per year for all the asthmatics per patient is about USD 1,900.
Asia Pacific is the fastest growing market due to the presence of a huge patient population, continuously developing economies like India and China, and the presence of huge opportunities in the market. Moreover, favorable government policies and increasing healthcare expenditure fuel the market within the region.
On the other hand, the Middle East & Africa holds the least share of the global respiratory therapeutic devices market due to the presence of poor economy, especially, within the African region. Majority of the market of this region is held by the Middle East due to the huge healthcare expenditure.
For more information, Please Visit us @ Market Research Future
The Respiratory Therapeutic Devices Market comprises a range of medical devices aimed at managing respiratory conditions like COPD, asthma, and sleep apnea. These devices, including inhalers, PAP machines, oxygen therapy, and ventilators, address diverse respiratory needs. Market growth is propelled by rising respiratory disease prevalence, technological advancements enhancing device efficacy and portability, and a focus on personalized care. Key players in this competitive market prioritize innovation and strategic partnerships to meet evolving patient demands. As the global burden of respiratory diseases continues to grow, the market is poised for further expansion in meeting patient needs and improving respiratory health outcomes.
The Respiratory Therapeutic Devices Market Size is anticipated to reach USD 12,231.6 Million by 2030 at 8.6% CAGR during the forecast period 2022-2030.
Breathing assistance devices are another key segment of the respiratory therapeutic devices market, aimed at providing assistance to individuals with compromised respiratory function. These devices include continuous positive airway pressure (CPAP) machines, bilevel positive airway pressure (BiPAP) machines, and nebulizers, among others. CPAP and BiPAP machines are commonly used to treat sleep apnea and other sleep-related breathing disorders by delivering a steady flow of air to keep the airways open during sleep. Nebulizers are used to deliver medication in the form of a mist or aerosol to the lungs, providing relief for respiratory conditions such as asthma and chronic bronchitis. The growing awareness of the importance of early diagnosis and treatment of respiratory conditions, coupled with technological advancements in breathing assistance devices, is driving market growth.
Key Players
Global Respiratory Therapeutic Devices Market Players are
Masimo. (U.S.),
- (U.S.),
- Hoffmann-La Roche Ltd (Europe),
Rotech Healthcare Inc. (U.S.),
Chart Industries (U.S.),
Acare Technology (Asia Pacific), and
others.
Segmentation
The global respiratory therapeutic devices market is segmented on the basis of product, technology, application, and end users.
On the basis of the product, the market is segmented into nebulizers, capnography, humidifiers oxygen concentrators, and others. The nebulizers segment is sub-segmented into soft mist inhaler, human-powered nebulizer, and others. The capnography segment is sub-segmented into main-stream capnography, side-stream capnography, and others.
On the basis of the technology, the market is segmented into electrostatic filtration, HEPA filtration, hollow fiber filtration, microsphere separation, and others.
On the basis of the application, the market is segmented into asthma, chronic obstructive pulmonary disease (COPD), cystic fibrosis, and others.
On the basis of the end users, the market is segmented into hospitals & clinics, retail pharmacies, home care, and others.
Regional Analysis
The Americas dominate the global respiratory therapeutic devices market insights owing to a huge patient population having cardiopulmonary diseases and well-developed healthcare sector. Moreover, the concentration of the global players like Masimo., BD., Smiths Group plc., besides others along with the increasing healthcare expenditure fuels the regional market growth during the forecast period. In 2015, according to the Centers for Disease Control and Prevention, in the U.S. the total healthcare expenditure accounted for 17.8% of the total gross domestic product (GDP), which accounted for USD 3.2 trillion.
Europe is the second largest respiratory therapeutic devices market owing to a well-developed healthcare infrastructure, government support for research & development, and huge patient population. In 2017, according to a study published in the Asthma Research and Practice Journal, the total estimated cost per year for all the asthmatics per patient is about USD 1,900.
Asia Pacific is the fastest growing market due to the presence of a huge patient population, continuously developing economies like India and China, and the presence of huge opportunities in the market. Moreover, favorable government policies and increasing healthcare expenditure fuel the market within the region.
On the other hand, the Middle East & Africa holds the least share of the global respiratory therapeutic devices market due to the presence of poor economy, especially, within the African region. Majority of the market of this region is held by the Middle East due to the huge healthcare expenditure.
For more information, Please Visit us @ Market Research Future
